SecBot SecBot
PRESS-RELEASE ·Filed Apr 13, 2026

SYK

Stryker Corporation
BULLISH
Impact 7/10
Horizonmonths Processed7mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight ▲ Bullish

Traders should monitor for potential regulatory filings or closing announcements. The addition of a novel IVL platform positions Stryker to capture share in the fast-growing calcium modification market, which could drive long-term revenue growth in the Peripheral Vascular segment.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$347.00
T+0 close · Apr 13, 2026 · via day close
Latest settled
−4.97%
T+60 · $329.74
Vs SPY
−13.95%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 13 $347.00entry
  2. T+1 · 7mo ago −0.33%α −1.54% · $345.86
  3. T+5 · 7mo ago −2.49%α −5.79% · $338.34
  4. T+20 · 6mo ago −18.58%α −26.30% · $282.54
  5. T+60 · 4mo ago −4.97%α −13.95% · $329.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Stryker announced a definitive agreement to acquire Amplitude Vascular Systems, a private developer of next-generation intravascular lithotripsy (IVL) technology for treating calcified peripheral arterial disease. The acquisition strengthens Stryker’s Peripheral Vascular portfolio and advances its strategy in arterial disease treatment, with the deal subject to customary closing conditions.

Key Facts

  • Stryker is acquiring Amplitude Vascular Systems (AVS), a privately held company developing a next-generation IVL platform for calcified peripheral arterial disease.
  • AVS’ technology uses pulsed CO₂-generated pressure waves via a balloon catheter to fracture calcium and improve luminal gain, enhancing deliverability and treatment efficiency.
  • The acquisition expands Stryker’s Peripheral Vascular (PV) portfolio and supports its strategy to build a comprehensive PV platform.
  • Transaction is subject to customary closing conditions; both companies will operate independently until closing.
  • AVS was founded in 2017 and is backed by BioStar Capital, Cue Growth Partners, and other global investors.

Financial Impact

Undisclosed amount; likely mid- to high-hundreds of millions given strategic fit and technology stage.

revenueR&D pipelinestrategic positioning

Risk Factors

  • Regulatory or antitrust delays could push back the close.
  • Integration risk if AVS’ technology does not scale as expected.
  • Potential for future dilution if financing is required, though none disclosed.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
75% bullish (36 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3272439

Track record

29 reports on SYK

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +23.40% at T+20 after the Oct 7, 2026 report. 7 of 10 went positive at some point.

Filters
  1. Nov 12, 20266d ago Court Ruling Neutral 3/10 Entry $309.64 Now $310.72 +0.35% settles Dec 14
  2. Nov 9, 20268d ago 8-K Neutral 2/10 Entry $324.29 Now $310.72 −4.18% settles Dec 9
  3. Nov 5, 202612d ago 144 Neutral 3/10 Entry $325.87 Now $310.72 −4.65% settles Dec 7
  4. Nov 4, 202613d ago S-3ASR Neutral 3/10 Entry $335.08 Now $310.72 −7.27% settles Dec 4
  5. Nov 3, 202614d ago Institutional Cluster Mixed 3/10 Entry $310.55 Now $310.72 +0.05% settles Dec 2
  6. Oct 29, 202619d ago 8-K Bearish 6/10 No price data
  7. Oct 29, 202619d ago Press Release Bearish 6/10 Entry $291.86 Now $310.72 −6.46% settles Nov 30
  8. Oct 26, 202622d ago Press Release Neutral 4/10 Entry $306.13 Now $310.72 +1.50% settles Nov 23
  9. Oct 20, 202629d ago PTAB Trial Bearish 5/10 Entry $297.60 Now $310.72 −4.41% settles Nov 18
  10. Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $275.25 to $339.65 Now $310.72 +12.89% ▲ +23.40% +24.74% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Thu (12h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 13, 2026